iSpecimen Inc. (NASDAQ:ISPC) Shares Shorted: Short Interest Up 92.3% in October

iSpecimen Inc. (NASDAQ:ISPC) saw a significant growth in short interest during the month of October. As of October 30th, there was short interest totaling 305,211 shares, a growth of 92.3% from the October 15th total of 158,754 shares. Based on an average trading volume of 412,744 shares, the short-interest ratio is presently 0.7 days. Currently, 13.8% of the company’s stock are sold short.

Analysts Set New Price Targets

Separately, Weiss Ratings raised shares of iSpecimen from a “sell (e)” rating to a “sell (e+)” rating in a report on Thursday, October 29th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company presently has an average rating of “Sell”.

iSpecimen Stock Performance

NASDAQ:ISPC traded down $0.04 during mid-day trading on Friday, hitting $0.66. 113,271 shares of the company’s stock traded hands, compared to its average volume of 305,883. The company has a fifty day moving average of $1.07 and a 200 day moving average of $4.25. iSpecimen has a twelve month low of $0.63 and a twelve month high of $27.44. The company has a market capitalization of $1.66 million, a P/E ratio of -0.01 and a beta of 1.54.

iSpecimen (NASDAQ:ISPC) last issued its quarterly earnings results on Friday, August 14th. The company reported ($0.98) earnings per share for the quarter. iSpecimen had a negative return on equity of 524.39% and a negative net margin of 2,445.40%. The business had revenue of $0.15 million during the quarter.

About iSpecimen

iSpecimen, Inc. (NASDAQ: ISPC) operates a technology-enabled marketplace that connects life sciences researchers with sources of human biospecimens. Its platform is designed to help pharmaceutical, biotechnology, diagnostic and academic organizations identify, search for and procure biological samples and associated clinical data for research and development. The company’s offerings support access to a range of specimen types, including blood, tissue and other human-derived samples obtained through healthcare providers, laboratories, biobanks and research institutions. iSpecimen also facilitates custom collection programs and related sourcing services intended to help customers obtain specimens that meet specific scientific, demographic and clinical requirements.